insights_auto
Why is EW up 2.90%?
Dive Deeperchevron_right
EW:NYSE
Edwards Lifesciences Corp
$94.44
arrow_upward
+2.90%(+2.66) 1D
$94.00
arrow_downward
-0.47% (-0.44)bedtimeAfter hours
Closed: Oct 29, 4:00:05β―PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EW...
Open
$92.63
High
$95.20
Low
$89.90
Mkt. cap
54.44B
Avg. vol.
3.52M
Volume
4.68M
P/E ratio
54.64
52-wk high
$96.29
52-wk low
$74.66
EPS
$1.73
Beta
0.87
Shares outstanding
576.40M
No. of employees
16K
Open
$92.63
High
$95.20
Low
$89.90
Mkt. cap
54.44B
Avg. vol.
3.52M
Volume
4.68M
P/E ratio
54.64
52-wk high
$96.29
52-wk low
$74.66
EPS
$1.73
Beta
0.87
Shares outstanding
576.40M
No. of employees
16K
News stories
From web sources and news partners
News Corp
·
5 hours ago
Edwards Lifesciences Corp. stock outperforms competitors on strong trading day
Seeking Alpha
·
15 hours ago
Edwards Lifesciences Continually Innovating Ahead Of Q3 Results, Cardio Portfolio Thrives
Profile
Edwards Lifesciences Corporation is an American medical technology company headquartered in Irvine, California, specializing in tissue heart valves and transcatheter technologies for the treatment of structural heart disease. The company has manufacturing facilities at the Irvine headquarters, as well as in Draper, Utah; Costa Rica; Singapore; and Limerick, Ireland. The company is also constructing a manufacturing plant in Moncada, near Valencia, Spain, with a β¬150 million investment. Production is scheduled to begin in 2027. Wikipedia
About Edwards Lifesciences Corp
CEO-
Employees16K
Founded1958
HeadquartersIrvine, California, United States
SectorMedical device
Websiteedwards.com